![Mandy Gaziel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mandy Gaziel
Corporate Officer/Principal chez Molecular Detection, Inc.
Profil
Mandy Gaziel is currently working as the Director of Quality Management at Molecular Detection, Inc. Prior to this, she worked as a Supervisor of Quality Assurance at Dexcel Pharma Technologies Ltd.
Postes actifs de Mandy Gaziel
Sociétés | Poste | Début |
---|---|---|
Molecular Detection, Inc.
![]() Molecular Detection, Inc. Medical SpecialtiesHealth Technology Molecular Detection, Inc. develops and commercializes molecular diagnostic tests to detect infectious diseases. It offers Detect-Ready methicillin-resistant Staphylococcus aureus (MRSA) panel that allows for the detection of MRSA. The company was founded by Aryeh L. Gassel in 2007 and is headquartered in Wayne, PA. | Corporate Officer/Principal | - |
Anciens postes connus de Mandy Gaziel
Sociétés | Poste | Fin |
---|---|---|
Dexcel Pharma Technologies Ltd.
![]() Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Molecular Detection, Inc.
![]() Molecular Detection, Inc. Medical SpecialtiesHealth Technology Molecular Detection, Inc. develops and commercializes molecular diagnostic tests to detect infectious diseases. It offers Detect-Ready methicillin-resistant Staphylococcus aureus (MRSA) panel that allows for the detection of MRSA. The company was founded by Aryeh L. Gassel in 2007 and is headquartered in Wayne, PA. | Health Technology |
Dexcel Pharma Technologies Ltd.
![]() Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Health Technology |